Doses may be adjusted based on individual response and tolerability
Tirzepatide is a dual-agonist weight loss drug thats currently on the market
Patients and physicians have reported severe gastrointestinal complications involving persistent vomiting, severe nausea, abdominal pain, dehydration, malnutrition, and delayed stomach emptying that, in some cases, required hospitalization or emergency room treatment
If a single dose of trial product was missed, it was to be administered as soon as noticed, provided the time to the next scheduled dose was at least 2 days (48 hours) away
Ozempic is not recommended for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or certain pancreatic conditions
Thankfully, both issues can be avoided with the right approach